In 2018, Yamaguchi et al. identified a TP53 gene expression signature consisting of 33 genes by performing nCounter analysis on early breast cancer FFPE samples, demonstrating its prognostic power for predicting early-stage breast cancer [29]. Here, TP53 is linked to breast carcinoma.